New report shows workforce being hit hard by diabetic eye disease 28 April 2015 The productivity of Australia’s workforce is being hit hard and may be even more so in the future by the impact of diabetic macular oedema (DME), according to a new report supported by Macular Disease Foundation Australia and Diabetes Australia. Key points: This year alone diabetic macular oedema (DME) is estimated to cost the country $2.07 billion in indirect economic costs, with a significant part due to reduced ability to work at full capacity and lost wellbeing caused by impaired vision.1 The impact is set to grow in coming years as the number of people living with diabetes is estimated to reach 2.45 million by 2030 and the prevalence of DME is estimated to rise by 42 per cent over the next 15 years.
Blog 27 July 2026 Round up for Diabetes Australia and turn small change into impact Learn how your spare change with Round up goes straight to Diabetes Australia to support programs, research, education, and advocacy. Continue Reading
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
Blog 22 July 2026 Living Out Loud: how Australia spoke up for National Diabetes Week 2026 From 12 to 18 July, Australians living with diabetes, alongside their carers, researchers, health professionals and clinicians, did something powerful. They... Continue Reading
